Preliminary Results Presentation for the year ended 31 March 2020
To view the presentation of the preliminary results for the year ended 31 March 2020 please click here.
A recording of the webcast can be accessed via the following link:
ARM Cell & Gene : Meeting on the Mesa – 2-4 October 2019
ARM Cell & Gene : Meeting on the Med – 23-25 April 2019
Association for research in vision and ophthalmology (ARVO) annual meeting 2019 : Jason Commander presentation
Proactive Investors ‘ReNeuron provides encouraging update to phase II eye disease trial’
Proactive Investors ‘ReNeuron Group’s phase IIb stroke trial kicks off with first patient treated’
Proactive Investors : “ReNeuron signs exosome collaboration deal with US biopharma”
OIS: Ophthalmology Innovation & Investment – ReNeuron using hRPCs to treat inherited retinal degenerative diseases
ReNeuron signs retinal stem cell exclusivity agreement
2017 AGM Trading Update – Shareholder Presentation
September 2017: Please click here to see the slides accompanying the AGM Trading Update presentation.